182 related articles for article (PubMed ID: 10837086)
1. Identification of a high frequency of chromosomal rearrangements in the centromeric regions of prostate cancer cell lines by sequential giemsa banding and spectral karyotyping.
Beheshti B; Karaskova J; Park PC; Squire JA; Beatty BG
Mol Diagn; 2000 Mar; 5(1):23-32. PubMed ID: 10837086
[TBL] [Abstract][Full Text] [Related]
2. Evidence of chromosomal instability in prostate cancer determined by spectral karyotyping (SKY) and interphase fish analysis.
Beheshti B; Park PC; Sweet JM; Trachtenberg J; Jewett MA; Squire JA
Neoplasia; 2001; 3(1):62-9. PubMed ID: 11326317
[TBL] [Abstract][Full Text] [Related]
3. Characterization of chromosomal abnormalities in prostate cancer cell lines by spectral karyotyping.
Pan Y; Kytölä S; Farnebo F; Wang N; Lui WO; Nupponen N; Isola J; Visakorpi T; Bergerheim US; Larsson C
Cytogenet Cell Genet; 1999; 87(3-4):225-32. PubMed ID: 10702678
[TBL] [Abstract][Full Text] [Related]
4. The use of multicolor fluorescence technologies in the characterization of prostate carcinoma cell lines: a comparison of multiplex fluorescence in situ hybridization and spectral karyotyping data.
Strefford JC; Lillington DM; Young BD; Oliver RT
Cancer Genet Cytogenet; 2001 Jan; 124(2):112-21. PubMed ID: 11172901
[TBL] [Abstract][Full Text] [Related]
5. Spectral karyotyping identifies recurrent complex rearrangements of chromosomes 8, 17, and 20 in osteosarcomas.
Bayani J; Zielenska M; Pandita A; Al-Romaih K; Karaskova J; Harrison K; Bridge JA; Sorensen P; Thorner P; Squire JA
Genes Chromosomes Cancer; 2003 Jan; 36(1):7-16. PubMed ID: 12461745
[TBL] [Abstract][Full Text] [Related]
6. Spectral karyotyping analysis of head and neck squamous cell carcinoma.
Singh B; Gogineni S; Goberdhan A; Sacks P; Shaha A; Shah J; Rao P
Laryngoscope; 2001 Sep; 111(9):1545-50. PubMed ID: 11568603
[TBL] [Abstract][Full Text] [Related]
7. Correlating breakage-fusion-bridge events with the overall chromosomal instability and in vitro karyotype evolution in prostate cancer.
Vukovic B; Beheshti B; Park P; Lim G; Bayani J; Zielenska M; Squire JA
Cytogenet Genome Res; 2007; 116(1-2):1-11. PubMed ID: 17268171
[TBL] [Abstract][Full Text] [Related]
8. Molecular cytogenetic analysis of glial tumors using spectral karyotyping and comparative genomic hybridization.
Squire JA; Arab S; Marrano P; Bayani J; Karaskova J; Taylor M; Becker L; Rutka J; Zielenska M
Mol Diagn; 2001 Jun; 6(2):93-108. PubMed ID: 11468694
[TBL] [Abstract][Full Text] [Related]
9. Identification of a high frequency of chromosomal rearrangements in the centromeric regions of prostate cancer patients.
Balachandar V; Lakshman Kumar B; Sasikala K; Manikantan P; Sangeetha R; Mohana Devi S
J Zhejiang Univ Sci B; 2007 Sep; 8(9):638-46. PubMed ID: 17726745
[TBL] [Abstract][Full Text] [Related]
10. Analysis of marker or complex chromosomal rearrangements present in pre- and post-natal karyotypes utilizing a combination of G-banding, spectral karyotyping and fluorescence in situ hybridization.
Heng HH; Ye CJ; Yang F; Ebrahim S; Liu G; Bremer SW; Thomas CM; Ye J; Chen TJ; Tuck-Muller C; Yu JW; Krawetz SA; Johnson A
Clin Genet; 2003 May; 63(5):358-67. PubMed ID: 12752567
[TBL] [Abstract][Full Text] [Related]
11. Molecular cytogenetic analysis of the bladder carcinoma cell line BK-10 by spectral karyotyping.
Padilla-Nash HM; Nash WG; Padilla GM; Roberson KM; Robertson CN; Macville M; Schröck E; Ried T
Genes Chromosomes Cancer; 1999 May; 25(1):53-9. PubMed ID: 10221340
[TBL] [Abstract][Full Text] [Related]
12. New chromosomal breakpoints in non-Hodgkin's lymphomas revealed by spectral karyotyping and G-banding.
Nordgren A; Sørensen AG; Tinggaard-Pedersen N; Blennow E; Larsson C; Lagercrantz S
Int J Mol Med; 2000 May; 5(5):485-92. PubMed ID: 10762651
[TBL] [Abstract][Full Text] [Related]
13. Combined GTG-banding and nonradioactive in situ hybridization improves characterization of complex karyotypes.
Smit VT; Wessels JW; Mollevanger P; Schrier PI; Raap AK; Beverstock GC; Cornelisse CJ
Cytogenet Cell Genet; 1990; 54(1-2):20-3. PubMed ID: 2249470
[TBL] [Abstract][Full Text] [Related]
14. Hidden chromosome abnormalities in haematological malignancies detected by multicolour spectral karyotyping.
Veldman T; Vignon C; Schröck E; Rowley JD; Ried T
Nat Genet; 1997 Apr; 15(4):406-10. PubMed ID: 9090389
[TBL] [Abstract][Full Text] [Related]
15. 5q11, 8p11, and 10q22 are recurrent chromosomal breakpoints in prostate cancer cell lines.
Pan Y; Lui WO; Nupponen N; Larsson C; Isola J; Visakorpi T; Bergerheim US; Kytölä S
Genes Chromosomes Cancer; 2001 Feb; 30(2):187-95. PubMed ID: 11135436
[TBL] [Abstract][Full Text] [Related]
16. Characterization of chromosome changes in two human prostatic carcinoma cell lines (PC-3 and DU145) using chromosome painting and comparative genomic hybridization.
Bernardino J; Bourgeois CA; Muleris M; Dutrillaux AM; Malfoy B; Dutrillaux B
Cancer Genet Cytogenet; 1997 Jul; 96(2):123-8. PubMed ID: 9216719
[TBL] [Abstract][Full Text] [Related]
17. Identification by C-banding of two human prostate tumour cell lines, 1013L and DU 145.
Hartley-Asp B; Billström A; Kruse E
Int J Cancer; 1989 Jul; 44(1):161-4. PubMed ID: 2744886
[TBL] [Abstract][Full Text] [Related]
18. Advances in the detection of chromosomal aberrations using spectral karyotyping.
Bayani J; Squire JA
Clin Genet; 2001 Feb; 59(2):65-73. PubMed ID: 11260203
[TBL] [Abstract][Full Text] [Related]
19. Identification of chromosomal structural alterations in human ovarian carcinoma cells using combined GTG-banding and repetitive fluorescence in situ hybridization (FISH).
Xu J; Wang N
Cancer Genet Cytogenet; 1994 May; 74(1):1-7. PubMed ID: 8194040
[TBL] [Abstract][Full Text] [Related]
20. The application of an in situ karyotyping technique for mesenchymal stromal cells: a validation and comparison study with classical G-banding.
Hwang SM; See CJ; Choi J; Kim SY; Choi Q; Kim JA; Kwon J; Park SN; Im K; Oh IH; Lee DS
Exp Mol Med; 2013 Dec; 45(12):e68. PubMed ID: 24357832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
